Lipella Pharmaceuticals Inc.
General ticker "LIPO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.8M (TTM average)
Lipella Pharmaceuticals Inc. does not follow the US Stock Market performance with the rate: -32.4%.
Estimated limits based on current volatility of 7.4%: low 0.31$, high 0.36$
Factors to consider:
- Total employees count: 7 (+40.0%) as of 2023
- Top business risk factors: Going concern, Product development delays, Labor/talent shortage/retention, Product liability, Regulatory and compliance
- Current price 76.7% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.71$, 5.25$]
- 2025-12-31 to 2026-12-31 estimated range: [1.48$, 4.55$]
Financial Metrics affecting the LIPO estimates:
- Positive: with PPE of -0.6 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -127.10 <= 0.33
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 71.79 > 63.39
Short-term LIPO quotes
Long-term LIPO plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.18MM | $0.45MM | $0.54MM |
| Operating Expenses | $2.77MM | $5.20MM | $5.62MM |
| Operating Income | $-2.59MM | $-4.75MM | $-5.08MM |
| Non-Operating Income | $-0.01MM | $0.13MM | $0.06MM |
| Interest Expense | $0.01MM | $0.01MM | $0.00MM |
| R&D Expense | $2.55MM | $3.04MM | $0.00MM |
| Income(Loss) | $-2.60MM | $-4.62MM | $-5.02MM |
| Profit(Loss)* | $-2.60MM | $-4.62MM | $-5.02MM |
| Stockholders Equity | $4.68MM | $3.14MM | $1.92MM |
| Assets | $5.95MM | $3.58MM | $2.67MM |
| Operating Cash Flow | $-1.83MM | $-3.15MM | $-3.95MM |
| Capital expenditure | $0.00MM | $0.01MM | $0.00MM |
| Investing Cash Flow | $0.30MM | $-0.01MM | $0.00MM |
| Financing Cash Flow | $5.24MM | $1.34MM | $2.84MM |
| Earnings Per Share** | $-5.12 | $-6.16 | $-4.79 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.